Rob Silberstein

Rob Silberstein serves as the Principal at Silberstein & Associates, bringing over 20 years of legal expertise to the forefront of his practise. His extensive background encompasses both in-house and private practise roles, having held senior positions in the industry. Since April 2014, Rob has been leading the firm, which is renowned for its deep focus on Intellectual Property, Litigation, and Corporate & Commercial Law. Silberstein & Associates collaborates with a diverse clientele, including individuals, entrepreneurs, and corporations, providing strategic advice across multiple jurisdictions. In Intellectual Property, Rob's proficiency covers registration, commercialisation, and enforcement. His technical acumen extends to sectors such as pharmaceuticals, medical devices, and IT, with significant involvement in patent oppositions, trademark disputes, and patent litigation. On the litigation front, he adeptly manages contentious matters before reaching court, appearing before bodies like IP Australia and the Federal Court of Australia. Rob's Corporate & Commercial acumen includes negotiating and drafting various agreements, as well as guiding clients through M&A transactions and compliance with the ASX Listing Rules. His firm supports clients with corporate governance and asset protection strategies, offering insights into private equity, venture capital, and joint ventures. Beyond his primary role, Rob dedicates time to pro bono work with the Arts Law Centre Australia and serves as Director at Northcott Innovation, contributing to community development. His prior experience includes handling IP matters at Alphapharm, where he was involved in both regional and global teams, addressing complex regulatory and compliance issues. Additionally, Rob has served as a Senior Associate at Allens Arthur Robinson and held various roles focused on intellectual property and technology transfer. Rob's educational credentials include an LLB (Hons 1) from the University of Sydney, an MIP in Intellectual Property from the University of Technology Sydney, and an MHL in Medical Law from the University of Sydney. His foundational studies in medicine and surgery further complement his legal expertise, providing a unique perspective in his specialised fields.